Molecular Pathology of Lung Cancer

As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.

Philip T. Cagle, MD
The Methodist Hospital, Houston, TX, USA

Timothy Craig Allen, MD, JD
The University of Texas Health Science Center at Tyler, TX, USA

Mary Beth Beasley, MD
Mount Sinai Medical Center, New York, NY, USA

Lucian R. Chirieac, MD
Brigham and Women's Hospital, Boston, MA, USA

Sanja Dacic, MD, PhD
University of Pittsburgh Medical Center, PA, USA

Alain C. Borczuk, MD
Columbia University Medical Center, New York, NY, USA

Keith M. Kerr, MD, FRCPath
Aberdeen University Medical School, Scotland, UK